Lineage Cell Therapeutics, Inc. and ________, As Warrant Agent Form of Common Share Warrant Agreement Dated as of _____________Common Share Warrant Agreement • March 11th, 2021 • Lineage Cell Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 11th, 2021 Company Industry JurisdictionThis Common Share Warrant Agreement (this “Agreement”), dated as of __________between Lineage Cell Therapeutics, Inc., a California corporation (the “Company”) and _________, a [corporation] [national banking association] organized and existing under the laws of __________ and having a corporate trust office in ________ , as warrant agent (the “Warrant Agent”).
AXOVANT GENE THERAPIES LTD. and , AS WARRANT AGENT FORM OF COMMON SHARE WARRANT AGREEMENT DATED AS OFCommon Share Warrant Agreement • January 10th, 2020 • Axovant Gene Therapies Ltd. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 10th, 2020 Company Industry JurisdictionCOMMON SHARE WARRANT AGREEMENT (this “Agreement”), dated as of between AXOVANT GENE THERAPIES LTD., a Bermuda Exempted Limited Company (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
MYOVANT SCIENCES LTD. and , AS WARRANT AGENT FORM OF COMMON SHARE WARRANT AGREEMENT DATED AS OFCommon Share Warrant Agreement • November 13th, 2017 • Myovant Sciences Ltd. • Pharmaceutical preparations • New York
Contract Type FiledNovember 13th, 2017 Company Industry JurisdictionCOMMON SHARE WARRANT AGREEMENT (this “Agreement”), dated as of between MYOVANT SCIENCES LTD., a Bermuda Exempted Limited Company (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
SOPHIRIS BIO INC. and ________, AS WARRANT AGENT FORM OF COMMON SHARE WARRANT AGREEMENT DATED AS OF [__], 20___Common Share Warrant Agreement • August 10th, 2017 • Sophiris Bio Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 10th, 2017 Company Industry JurisdictionCommon Share Warrant Agreement (this “Agreement”), dated as of between Sophiris Bio Inc. (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
AXOVANT SCIENCES LTD. and , AS WARRANT AGENT FORM OF COMMON SHARE WARRANT AGREEMENT DATED AS OFCommon Share Warrant Agreement • December 30th, 2016 • Axovant Sciences Ltd. • Pharmaceutical preparations • New York
Contract Type FiledDecember 30th, 2016 Company Industry JurisdictionCOMMON SHARE WARRANT AGREEMENT (this “Agreement”), dated as of between AXOVANT SCIENCES LTD., a Bermuda Exempted Limited Company (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
SOPHIRIS BIO INC. and ________, AS WARRANT AGENT FORM OF COMMON SHARE WARRANT AGREEMENT DATED AS OF [__], 20___Common Share Warrant Agreement • September 16th, 2014 • Sophiris Bio Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 16th, 2014 Company Industry JurisdictionCommon Share Warrant Agreement (this “Agreement”), dated as of between Sophiris Bio Inc. (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).